Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. [electronic resource]
Producer: 20110719Description: 550-7 p. digitalISSN:- 2042-7158
- Acetates -- administration & dosage
- Administration, Oral
- Animals
- Antipyrine -- analogs & derivatives
- Atrophy -- prevention & control
- Behavior, Animal -- drug effects
- Brain Injury, Chronic -- complications
- Chromones -- therapeutic use
- Cyclopropanes
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Edaravone
- Free Radical Scavengers -- therapeutic use
- Infarction, Middle Cerebral Artery -- drug therapy
- Injections, Intraperitoneal
- Leukotriene Antagonists -- pharmacology
- Male
- Mice
- Mice, Inbred ICR
- Nerve Degeneration -- drug therapy
- Quinolines -- administration & dosage
- Rats
- Rats, Sprague-Dawley
- Sulfides
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.